The drugmaker will pay $21 per Fusion share, a premium of more than 97% to the U.S.-listed company's closing price on Monday. AstraZeneca will also pay a...
-AstraZeneca said on Tuesday it will buy clinical-stage biopharmaceutical company Fusion Pharmaceuticals Inc for about $2 billion in cash to boost its oncology portfolio.
AstraZeneca will also pay a non-transferable contingent value right of $3 per share, taking the combined transaction value to about $2.4 billion. Canadian retirees can consider supplementing their CPP payouts by investing in blue-chip dividend stocks such as RBC. The post Here’s the Average CPP Benefit at Age 70 appeared first on The Motley Fool Canada.Are you interested in buying dividend stocks for passive income in 2024? Here’s one stock I’m buying! The post 1 Dividend Stock I’m Buying for Superior Passive Income in 2024 appeared first on The Motley Fool Canada.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
AstraZeneca to buy Amolyt Pharma for US$1.05-billion to boost rare-disease portfolioThe deal, which includes an $800-million upfront payment and an additional contingent payment of $250-million on achieving a specified regulatory milestone, is expected to close by the third quarter of 2024
Lire la suite »
KKR Considers Selling Stake in India’s $3 Billion JB Pharma, Sources SayKKR & Co. is exploring options including selling its controlling stake in India’s JB Chemicals & Pharmaceuticals Ltd. amid interest from potential buyers, according to people familiar with the matter.
Lire la suite »
Former Muio's building to become a plant-based South Asian fusion eaterySurendra Kumar Bansal and Oyunbileg Chuluunbazar have leased the former Muio's building in Sault Ste. Marie to open a plant-based, South Asian fusion eatery named Ojas. The restaurant aims to promote a balanced lifestyle and nourishing foods.
Lire la suite »
Vancouver readies for its position as a global pharma capital as B.C.'s biotech boom takes offVancouver’s life sciences scene dates to the first biotech boom in the early 1980s. Toronto and Montreal also produced biotechs, but Vancouver had several advantages, such as risk-tolerant investors and the city’s natural beauty
Lire la suite »
Pfizer Leases Space at San Diego Campus for Cancer-Drug PushPfizer Inc.’s oncology division is taking space at a newly built life-sciences complex in San Diego, as the pharma giant redefines itself as a cancer-drug powerhouse.
Lire la suite »
YYC EXP: Calgary's Culinary FestivalYYC EXP is a culinary festival in Calgary celebrating the city's dining scene with prix-fixe menus at various restaurants and special culinary events. The festival offers multi-course menus from over 90 restaurants, allowing visitors to experience something different at their favorite spots or try out new ones. The events include chef and restaurant collaborations and unique dining experiences. From martini-making masterclasses to fusion dinners, there is something for everyone. Sign up for weekly suggestions on experiencing Calgary's food scene.
Lire la suite »